The fructosamine reagents market is projected to acquire a 4% CAGR during the forecast period 2022-2032.
The higher sales of fructosamine reagents can be attributed to the lesser time-consumption by fructosamine when compared to the glucose concentration provided by haemoglobin.
| Attributes | Details |
| Fructosamine Reagents Market CAGR | 4% |
| Fructosamine Reagents Market Value (2022) | US$ 4.3 Bn |
Longer lifespan of glycohemoglobin do not reflect the changes in the glucose concentration more efficiently hence fructosamine is preferred for the measurement of the glucose level in the diabetic patients thereby spiking the demand for fructosamine reagents around the globe.
In addition, the rising sales of fructosamine reagents is also due to the prevalence of diabetes in developed as well as developing countries is increasing due to various factors such as family history of diabetes.
One other major propeller of demand for fructosamine reagents is the widespread obesity (majorly due to change in the lifestyle), as increasing prevalence of diabetes add up to the cost of management of diabetes.
The report sheds light on the factors improving the sales of fructosamine reagents, and, in turn, the opportunities for the market players. However, the fructosamine reagents market also faces some challenges, which might limit the fructosamine market share from reaching its potential.
Increasing prevalence of diabetes across the world expected to drive the demand for fructosamine reagents in coming years.
With severity of the diabetes is on increase and requiring monitoring frequently expected to reflect in the global sales of fructosamine reagents.
With need for frequent and real time monitoring of the glucose level among diabetes patients is increasing the fructosamine reagents provides exact mechanism which in turn expected to boost the sales of fructosamine reagents.
The demand for fructosamine reagents is on the surge also due to the widespread availability of the fructosamine reagents is expected to scale up the sales of fructosamine reagents.
Increasing per capita expenditure on the evaluating the glucose level testing provides impetus to the overall demand for fructosamine reagents.
Whereas, economic nature of HbA1C test is the prime impediment to the growing sales of fructosamine reagents in various countries thereby dwindling the fructosamine reagents market share.
However, increasing number of global and regional fructosamine reagents manufacturers expected to augment the demand for fructosamine reagents for glucose monitoring, in turn, peaking the sales of fructosamine reagents.
North America is expected to witness the highest demand for fructosamine reagents in the global fructosamine reagents market owing to higher prevalence of the diabetes.
Latin America fructosamine reagents market is expected to witness steady rise in the sales of fructosamine reagents during the forecast period owing to increasing product availability in the region.
Europe fructosamine reagents market is exhibit second most lucrative region in terms of sales of fructosamine reagents due to higher adoption of fructosamine test assays.
Asia-Pacific is projected to experience growing demand for fructosamine reagents owing to increasing diagnosed prevalence of diabetes in the region.
Middle East & Africa fructosamine reagents market is expected witness the least demand for fructosamine reagents on account of lower product availability in the region.
The key participants operating in the global fructosamine reagents market are: Randox Laboratories Ltd., Sekisui Diagnostics, Biosystems S.A., Kamiya Biomedical Co., Sentinel Diagnostics, Asahi Kasei Pharma Corporation, and others.
The report consists of key players, contributing to the fructosamine reagents market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions thereby augmenting the demand for fructosamine reagents worldwide.
This exclusive report analysis the competitive landscape and fructosamine reagents market share acquired by players to strengthen their market position.
| Report Attribute | Details |
| Base year for estimation | 2021 |
| Historical data | 2015 - 2020 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Disease, End Use, Region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | Randox Laboratories Ltd., Sekisui Diagnostics, Biosystems S.A., Kamiya Biomedical Co., Sentinel Diagnostics, Asahi Kasei Pharma Corporation, and others. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
North America is expected to hold the highest demand for fructosamine reagents market share owing to higher prevalence of the diabetes.
Randox Laboratories Ltd., Sekisui Diagnostics, Biosystems S.A., Kamiya Biomedical Co., Sentinel Diagnostics are a few key players.
Economic nature of HbA1C test is the prime impediment to the growing demand for fructosamine reagents in various countries.
Explore Similar Insights
Fructosamine Reagents Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
